
Kansas Laboratories Pvt Ltd
About Kansas Laboratories Pvt Ltd
Data last updated:
Kansas Laboratories Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 November 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U27109WB1986PTC041462. Its GSTIN is 19AABCK0703A1ZA (West Bengal). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹60.62 Lakh. It is led by directors including Neerav Shah and Dipak Kumar Kantilal Shah.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.04 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹52.19 Lakh (net margin 3.5%) and EBITDA of ₹87.42 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 5% over five years.
The company has about 62 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹1.73 Cr on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Kansas Laboratories has one previous CIN (Corporate Identification Number): U91397WB1986PTC041462. The current CIN is U27109WB1986PTC041462, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U27109WB1986PTC041462 | Current |
| U91397WB1986PTC041462 | Previous |
Contact details
Kansas Laboratories Pvt Ltd's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address8/1 Lal Bazar Street, Room No. 3 Mezannine Floor, Kolkata, West Bengal, India – 700001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kansas Laboratories Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Kansas Laboratories are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kansas Laboratories Pvt Ltd, buy the company report.
Financials of Kansas Laboratories Pvt Ltd
FY 2025 filings availableKansas Laboratories Pvt Ltd reported revenue of ₹15.04 Cr (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 13% growth in the latest year. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹87.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kansas Laboratories Pvt Ltd, buy the company report.
Board of directors of Kansas Laboratories Pvt Ltd
Kansas Laboratories has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neerav Shah | Director | 14 Sep 2023 | 3 Years 1 Months | Current |
| Dipak Kumar Kantilal Shah Also directs: Kansas Drugs & Pharmaceuticals Pvt.Ltd. | Director | 03 Nov 1986 | 40 Years 0 Months | Current |
| Anil Kumar Shah | Director | 03 Nov 1986 | 40 Years 0 Months | Current |
| Subir Dutta | Director | 15 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Kansas Laboratories Pvt Ltd is compared with the 7 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Coax Bioremedies Private Limited | ₹15.08 Cr (FY 2025) | 33.0% | Haryana, India | |||
| Kras Pharmaceuticals Private Limited | ₹15.05 Cr (FY 2025) | 45.0% | Fatuha, Bihar, India | |||
| Kansas Laboratories Pvt Ltdthis company | ₹15.04 Cr (FY 2025) | ₹52.19 Lakh | 3.5% | 13.0% | 62 | Kolkata, West Bengal, India |
| Grindlays Pharmaceuticals Pvt Ltd | ₹14.96 Cr (FY 2025) | 69.0% | Mumbai, Maharashtra, India | |||
| Santexo Pharma Private Limited | ₹14.95 Cr (FY 2025) | 86.0% | New Delhi, Delhi, India | |||
| Revive Formulations India Private Limited | ₹14.93 Cr (FY 2024) | 5.0% | Vanur, Tamil Nadu, India | |||
| Theo Pharma Pvt Ltd | ₹14.91 Cr (FY 2025) | 26.0% | Ahmedabad, Gujarat, India | |||
| Raymed Pharmaceuticals Limited | ₹14.9 Cr (FY 2025) | -2.0% | Chandigarh, India |
To see the full peer comparison of Kansas Laboratories Pvt Ltd, buy the company report.
Auditor
Kansas Laboratories Pvt Ltd is audited by SUSHIL SHARMA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUSHIL SHARMA & CO | FY 2023 | 312098E |
Shareholding
The shareholding of Kansas Laboratories Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kansas Laboratories Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Nov 2006 | 10027297 | Canara Bank | ₹1.73 Cr | Satisfied |
To see the full charge records of Kansas Laboratories Pvt Ltd, buy the company report.
Total charge records: 1 View all charges
Legal cases
Kansas Laboratories Pvt Ltd has 7 court cases on record: 3 filed by Kansas Laboratories, 4 filed against it. 2 cases are pending and 5 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 4 | 2 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against individuals | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by State at the Instance of Drugs Inspector | Pending |
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Filed against the company by State at the Instance of Drugs Inspector | Disposed |
| District court, Deoghar, Jharkhand | Court case (Drugs and Cosmetic act) | Filed against the company by State Through Kumar Rajneesh Singh | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Kansas Laboratories Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kansas Laboratories Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kansas Laboratories Pvt Ltd has a workforce of 62 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
Kansas Laboratories has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AABCK0703A1ZA | West Bengal | Active | 01 Jul 2017 |
| 332400000669RFW | Tamil Nadu | Active | 30 Aug 2024 |
To see the full GST registrations and return filing status of Kansas Laboratories Pvt Ltd, buy the company report.
Recent activity
Kansas Laboratories Pvt Ltd has 6 board changes on record since 1986: 4 appointments and 2 cessations. The latest: Subir Dutta was appointed as Director on 15 May 2024.
Frequently asked questions
Kansas Laboratories is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 November 1986 (40+ years old) and is registered under CIN U27109WB1986PTC041462.
Kansas Laboratories has 4 current directors:
- Neerav Shah - Director
- Dipak Kumar Kantilal Shah - Director
- Anil Kumar Shah - Director
- Subir Dutta - Director
The latest financial statements of Kansas Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kansas Laboratories is 19AABCK0703A1ZA, registered in West Bengal. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 332400000669RFW (Tamil Nadu).
The CIN (Corporate Identification Number) of Kansas Laboratories is U27109WB1986PTC041462. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kansas Laboratories has 7 court cases on record: 3 filed by the company and 4 filed against it. 2 are pending.
Kansas Laboratories was incorporated on 03 November 1986, making it 40+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Kansas Laboratories by revenue are Coax Bioremedies Private Limited, Kras Pharmaceuticals Private Limited, Grindlays Pharmaceuticals Pvt Ltd, Santexo Pharma Private Limited, Revive Formulations India Private Limited and 2 more, all in the Healthcare industry (Ayurvedic Products and Services, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Subir Dutta was appointed as Director on 15 May 2024. Neerav Shah ceased to be Additional Director on 29 Sep 2023. Neerav Shah was appointed as Director on 14 Sep 2023. Kansas Laboratories has 6 board changes on record in total.
The registered office of Kansas Laboratories is at 81 Lal Bazar Street, Room No. 3 Mezannine Floor, Kolkata, West Bengal, India – 700001.
Kansas Laboratories operates in the pharma industry, in the drug formulation and development segment.

